4-[3-(Benzenesulfonyl)-4,6-dimethylpyridin-2-yl]morpholine

Catalog No. :
ACTEVA099
CAS No. :
339017-01-5
Molecular Formula :
C17H20N2O3S
Molecular Weight :
332.42

IUPAC Name:4-(4,6-dimethyl-3-(phenylsulfonyl)pyridin-2-yl)morpholine

4-[3-(Benzenesulfonyl)-4,6-dimethylpyridin-2-yl]morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$330.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[3-(Benzenesulfonyl)-4,6-dimethylpyridin-2-yl]morpholine
IUPAC Name4-(4,6-dimethyl-3-(phenylsulfonyl)pyridin-2-yl)morpholine
MDL No.MFCD01315748
Molecular FormulaC17H20N2O3S
Molecular Weight332.42
SMILESCC1=CC(C)=C(S(=O)(C2=CC=CC=C2)=O)C(N3CCOCC3)=N1
InChI KeyCGKJKPDFNMSLGD-UHFFFAOYSA-N
Synonym4,6-DIMETHYL-2-MORPHOLINO-3-PYRIDINYL PHENYL SULFONE;4-[4,6-DIMETHYL-3-(PHENYLSULFONYL)-2-PYRIDINYL]MORPHOLINE;4-[3-(benzenesulfonyl)-4,6-dimethylpyridin-2-yl]morpholine;Morpholine, 4-[4,6-dimethyl-3-(phenylsulfonyl)-2-pyridinyl]-
CAS No.339017-01-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTEVA099 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTEVA099 route product structure diagram
    ACTEVA099339017-01-5
Inquiry

2. ACTEVA099 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUXIA380 route compound structure diagram
    ACUXIA38025932-11-0 In Stock
  4. Then
  5. ACTEVA099 route product structure diagram
    ACTEVA099339017-01-5
Inquiry

Comments (0)